472 related articles for article (PubMed ID: 17608887)
1. Increasing generic drug use in Medicare Part D: the role of government.
Kohl H; Shrank WH
J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887
[No Abstract] [Full Text] [Related]
2. Affordable prescription drugs--state and federal action.
Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
[No Abstract] [Full Text] [Related]
3. AWP reimbursement scrutinized by several states.
Carroll J
Manag Care; 2003 Apr; 12(4):11-2. PubMed ID: 12747021
[No Abstract] [Full Text] [Related]
4. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
[No Abstract] [Full Text] [Related]
5. Medicare prescription plan, threat to AWP could impact the ESRD drug market.
Neumann ME
Nephrol News Issues; 2003 Jan; 17(2):16-7, 21. PubMed ID: 12629823
[No Abstract] [Full Text] [Related]
6. Economic aspects of the new Spanish laws on pharmaceutical preparations.
Antoñanzas F; Oliva J; Pinillos M; Juàrez C
Eur J Health Econ; 2007 Sep; 8(3):297-300. PubMed ID: 17401592
[TBL] [Abstract][Full Text] [Related]
7. The cost of prescription drugs.
Havighurst C; Reynolds WN
N C Med J; 2004; 65(1):54. PubMed ID: 15052715
[No Abstract] [Full Text] [Related]
8. The impact of Medicare Part D on prescription drug use by the elderly.
Lichtenberg FR; Sun SX
Health Aff (Millwood); 2007; 26(6):1735-44. PubMed ID: 17978393
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceuticals and Medical Devices: Medicare Part D.
Steiner DJ;
Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-31. PubMed ID: 28252885
[No Abstract] [Full Text] [Related]
10. Perspectives. Will we try to manage care again? This time, for drugs?
Clemmitt M
Med Health; 2000 Jun; 54(25):suppl 1-4. PubMed ID: 11009923
[No Abstract] [Full Text] [Related]
11. Advocating for a Medicare prescription drug benefit.
Rother J
Yale J Health Policy Law Ethics; 2003; 3(2):279-90. PubMed ID: 14577144
[No Abstract] [Full Text] [Related]
12. What will the new medicare drug benefit mean for Minnesota physicians?
Liebow M
Minn Med; 2005 Mar; 88(3):38-41. PubMed ID: 15852596
[TBL] [Abstract][Full Text] [Related]
13. Who'll get soaked if Medicare covers drugs?
Moskowitz DB
Bus Health; 2000; 18(10):33-5, 38. PubMed ID: 11213766
[No Abstract] [Full Text] [Related]
14. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
Fise T
Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
[No Abstract] [Full Text] [Related]
15. Medicare and the politics of prescription drug pricing.
Oberlander J
N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
[No Abstract] [Full Text] [Related]
16. Medicare Part D: primer.
Coakley C
Adv Nurse Pract; 2006 Sep; 14(9):24. PubMed ID: 16972439
[No Abstract] [Full Text] [Related]
17. House says "yes" to Medicare Part D price negotiations, passes legislation.
Consult Pharm; 2007 Mar; 22(3):254. PubMed ID: 17691158
[No Abstract] [Full Text] [Related]
18. Discounts on your Rx drugs.
Quinn JB
Newsweek; 2001 Aug; 138(6):25. PubMed ID: 11499272
[No Abstract] [Full Text] [Related]
19. The implications of a Medicare prescription drug benefit.
Manag Care Interface; 2000 May; 13(5):44-5. PubMed ID: 11067393
[No Abstract] [Full Text] [Related]
20. Access to Medicare Part D gap coverage more scarce in 2007.
Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
